格隆汇10月6日｜英国财政大臣里夫斯与高盛资深投行家安东尼·古特曼将于周一共同主持一场闭门圆桌 会议，邀请科技及其他成长型行业的企业高管，以推介伦敦作为IPO的可行目的地。英国财政部组织此 次会议，旨在听取各方对伦敦上市吸引力的看法，并展示近期为提升资本市场竞争力而进行的一系列改 革。数据显示，今年8月伦敦市场IPO融资额创下了30年来的最低纪录。在全球IPO融资排名中，伦敦如 今已跌至第23位，甚至落后于墨西哥。一些竞争对手认为，高盛直接参与由英国财政部主导的会议实属 罕见，这相当于让其获得了一个向潜在上市公司免费推介的机会。此举也反映出英国对其金融地位日益 加深的担忧。 ...

格隆汇9月30日｜高盛策略师称，欧洲的 IPO 市场仍处于"低迷状态"，他们指出，在第三季度实现全面 重启之后，该地区落后于美国。包括吉马尔·贾西翁在内的团队表示，第三季度是美国市场多年来表现 最强劲的一个季度，而欧洲市场则依然低迷。 ...

规模最大的IPO收益最为丰厚。募资额超过10亿美元的IPO平均暴涨77%，凸显出投资者对规模和流动 性的偏好。表现突出的公司包括上涨324%的Circle(CRCL.US)、涨幅超过233%的 CoreWeave(CRWV.US)，以及上市以来上涨83%的Bullish(BLSH.US)。 德勤美国资本市场交易主管威尔·布劳蒂加姆表示："今年IPO的表现得益于多个支撑因素，但最重要的 或许是成功会带来更多成功。"他列举了自2024年以来新上市公司的正回报、散户兴趣上升以及当前上 市公司的相对成熟度。 今年以来，企业在美国交易所已融资320亿美元，这是在4月份关税引发市场不确定性导致市场动荡后的 强劲反弹。仅9月份就成为2021年以来IPO最繁忙的月份，因股市普遍上涨鼓励了一波发行潮。 寻求下一个华尔街热点的股票多头，正将目光转向今年美国市场最繁忙的角落—— IPO 市场。 智通财经APP注意到，新上市公司的股价表现已大幅跑赢基准指数。2025年，在美国交易所上市的公司 (排除空白支票公司等金融载体)的加权平均表现飙升41%，这一数字是标普500指数和纳斯达克100指数 涨幅的两倍多。 如此强劲的表现正引发银行 ...

2025.09. 25 本文字数：2609，阅读时长大约4分钟 作者 | 第一财经 魏中原 三季度即将收官，尽管今年以来全球宏观经济环境复杂多变，但A股IPO市场展现出较强的韧性和活 力，上交所融资金额排名全球第五。 从发行节奏来看，A股前三季度共发行新股75只，上年同期69只，保持了稳中有升的态势。在融资 规模方面，前三季度IPO合计募集资金达743.72亿元，同比增长265亿元，主要受华电新能 （600930.SH）融资181.71亿元推动。值得一提的是，香港交易所前三季度发行66只新股，融资 额超1800亿港元，登顶全球融资额第一名。 年内A股牛市行情持续演绎，新股赚钱效应更是显著提升。上述75只新股首日平均收涨244%，较去 年同期提升近100个百分点，并且年内无一只新股破发。个别兼具题材与业绩的个股上市后股价迭创 新高，较发行价涨超10倍。 前三季度A股IPO募资超700亿元 另外，日前，德勤中国资本市场服务部发布的《2025年前三季度中国内地和香港新股市场回顾与展 望》数据显示，上交所以25只新股、454亿元融资额，排名全球前三季度IPO融资额第五名。 上述报告称， 港交所IPO融资额排名全球第一 ...

德勤指，展望最后一个季度香港新股市场将维持强劲势头,，将超越早前资本市场服务部为香港新股市 场2025年全年表现所作的预测。根据港交所目前正在处理超过230宗的上市申请，并有超过5宗超大型规 模集资，包括 A+H 的项目，预料今年全年香港将有超过80只新股上市，集资2500-2800亿港元，集资额 较今年6月中预测的2000亿港元，上调25-40%。除了以 A+H 的新股为主导外，医疗及医药公司、特专 科技公司和消费板块的公司上市也会成为市场的亮点。 格隆汇9月23日｜德勤9月22日发布《2025年前三季度中国内地和香港新股市场回顾与展望》，受惠于期 内有6只超大型新股上市,以新股集资额计算，港交所将继续夺得全球新股集资排名的冠军。上海证券交 易(上交所)和深圳证券交易所(深交所)则分别排名第五和第八位。 德勤预计，今年前三季度，香港将有66只新股(IPO)上市集资1823亿港元，新股数量较去年同期增加 47%，而集资额由去年同期的556亿港元上升228%，预计今年前9个月将有6只超大型新股上市，包括5 只 A+H 新股及1宗从 A+H 上市公司分拆出来的上市项目，另有4只大型新股上市，包括1只以同股不同 权 ...

here. Veto Sperudo is here. Veto, good to have you on.Really appreciate you joining us. Thank you very much. Thank you for having me.I think I'm going to bring you out to like hype me up like that every time. That was good, right. Let's get ready to rumble.But you would note that unfortunately I've got to temper those numbers a little bit because those numbers are for the big big deals. Are deals under a billion dollars getting any traction. Yeah, I mean as you noted, deals over five billion are up 50 to 70 ...

Core Viewpoint - Clara, a buy now pay later company, is pricing its IPO at $40 per share, valuing the company at approximately $15 billion, which is above its expected range [1] Group 1: IPO Market Dynamics - Recent IPOs like Figma and Bullish have seen significant initial demand but are trading well below their highs [1] - The current market conditions, including low VIX and decreasing interest rates, are seen as bullish for IPOs [5][7] - There is a growing pipeline of VC-backed tech companies ready to go public after a three-year bottleneck in the IPO market [6] Group 2: Company Valuation and Comparisons - Clara's valuation is compared to its closest competitor, Affirm, which has higher margins due to its focus on the US market, while Clara is more international [2][3] - Clara's previous valuation was $46 billion, which is now considered overvalued compared to its current $15 billion valuation [4] Group 3: Pricing Strategy and Market Perception - The pricing of IPOs involves a delicate balance between raising capital and ensuring a strong market debut, as seen with Figma's significant price increase post-IPO [9][12] - The excitement generated by recent IPOs can influence investor perception and demand for new offerings like Clara [8][10] - IPOs serve as a marketing event, and generating investor interest is crucial for long-term success [12][13]

Group 1: Market Overview - The Hang Seng Index closed up 62 points or 0.25%, ending at 24,969, after fluctuating around the 25,000 level throughout the day [3][4] - The total market turnover was 215.42 billion, with a net inflow of 9.45 billion from northbound trading [3] - The technology index fell by 0.38%, indicating weakness in tech stocks, while the national index rose by 0.32% [3][4] Group 2: IPO Market - Hong Kong's IPO market is leading globally, with a total of 53 new listings in the first seven months of the year, raising approximately 127 billion, a year-on-year increase of over six times [7] - The strong performance is attributed to steady regulatory improvements and market reforms, with expectations for further developments in the second half of the year [7] Group 3: Company News - 康基医疗 (康基医疗) announced a privatization offer at a cash price of 9.25 HKD per share, representing a premium of about 9.9% over the last closing price [12] - 毛戈平 (毛戈平) expects a net profit growth of 35% to 37% for the first half of the year, driven by strong brand recognition and consumer demand [13] - 朗廷 (朗廷) reported a 17.65% decline in interim distributable income, with hotel revenue down 4.58%, citing geopolitical tensions and changing consumer behavior as key challenges [14] - 康健国际医疗 (康健国际医疗) anticipates turning a profit for the first half of the year, with expected earnings between 9.1 million to 14.3 million, compared to a loss of 47.7 million in the same period last year [15]

Group 1 - Hong Kong's capital market demonstrated exceptional resilience and institutional strength in the first half of the year, leading the global IPO fundraising with a total of approximately HKD 127 billion, a year-on-year increase of over six times [1] - A total of 53 new listings were recorded in the first seven months, surpassing the total fundraising amounts of each of the past three years [1] - The global IPO market saw only a 10% year-on-year increase in fundraising, with a 5% decline in the number of transactions, highlighting Hong Kong's leading position [1] Group 2 - Among the new listings, four raised over HKD 50 billion, and seven were "A+H" shares, collectively raising about HKD 77 billion, indicating Hong Kong's role as a key bridge between domestic and international capital markets [2] - The IPO market in Hong Kong is characterized by a diverse industry distribution, including sectors such as industrial, financial, consumer, healthcare, technology, media, telecommunications (TMT), and renewable energy [2] - The healthcare sector stood out with 10 companies successfully listed, raising a total of HKD 16.3 billion, with significant interest in innovative drugs and advanced medical technologies [2] Group 3 - International companies from Thailand, Singapore, and Southeast Asia have listed on the Hong Kong stock market, reinforcing its status as a preferred listing venue for international enterprises [3] - The active participation of international investors, including long-term funds and private equity from North America, Europe, and the Middle East, has contributed to a vibrant IPO market [3] - The retail market also showed strong engagement, with some new stocks experiencing multiple times oversubscription, enhancing overall market liquidity [3] Group 4 - The robust performance of the Hong Kong IPO market is attributed to long-term institutional innovations and policy support, including the expansion of the Stock Connect program and reforms in the listing system [4] - Recent measures include requiring at least 40% of shares to be allocated to cornerstone and institutional placements during IPOs, and introducing new public subscription mechanisms to enhance pricing and allocation stability [4][5] - These reforms aim to improve institutional robustness and facilitate effective capital allocation, fostering a balanced and trustworthy market environment [5] Group 5 - The capital market is a core engine driving Hong Kong's economic growth, with a real GDP growth of 3.1% year-on-year in the second quarter, supported by strong performance in financial and related services [6][7] - The Hong Kong government aims to continuously optimize institutional design and promote regulatory innovation to enhance market efficiency and competitiveness [7]

Group 1 - The core viewpoint is that innovative enterprises in China are becoming a significant force in economic growth, contributing 38.7% to GDP increment and surpassing 45 million in total number [2] - Innovative enterprises have created 120 million jobs over the past year, with leading companies driving 20 million flexible jobs through adaptable employment platforms [2] - Chinese innovative enterprises rank among the top globally in international patent applications, showcasing their technological advancements [2] Group 2 - The "Investment Value Enterprise List 2025" aims to identify innovative enterprises that contribute meaningfully to the Chinese economy, providing valuable industry reference for both primary and secondary markets [3] - The evaluation criteria for the list include five dimensions: financing, technology, product, team, and influence, assessing the overall performance of companies in the industry [5] - The list will feature various categories, including the most investment-worthy enterprises, the most anticipated IPOs, and innovation in sectors like digital economy, high-end manufacturing, and artificial intelligence [7]